Nextgen
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
Nextgen (NXGN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.111x
Based on the latest financial reports, Nextgen (NXGN) has a cash flow conversion efficiency ratio of 0.111x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.08 Million) by net assets (ILA-9.72 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nextgen - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Nextgen's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nextgen Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nextgen ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Abattis Bioceuticals Corp
PINK:ATTBF
|
0.369x |
|
Shinyoung HappyTomorrow No. 8 Special Purpose Acquisition Co.
KQ:430220
|
N/A |
|
Green Giant Inc.
NASDAQ:GGEI
|
-0.269x |
|
KINGDEE INTL SOFTWA
BE:KDIC
|
N/A |
|
PURPOSE MARIJ.OPP. TR.UTS
F:43V
|
N/A |
|
Nabors Energy Transition Corp. II Warrant
NASDAQ:NETDW
|
-0.004x |
|
Thanachart Capital PCL
STU:NVAK
|
0.007x |
|
MGLU3F
SA:MGLU3F
|
N/A |
Annual Cash Flow Conversion Efficiency for Nextgen (2013–2024)
The table below shows the annual cash flow conversion efficiency of Nextgen from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA-2.46 Million | ILA-2.06 Million | 0.837x | -81.41% |
| 2023-12-31 | ILA-979.00K | ILA-4.41 Million | 4.499x | +2102.13% |
| 2022-12-31 | ILA12.25 Million | ILA-2.75 Million | -0.225x | -75.07% |
| 2021-12-31 | ILA20.71 Million | ILA-2.66 Million | -0.128x | +42.64% |
| 2020-12-31 | ILA6.87 Million | ILA-1.54 Million | -0.224x | +77.11% |
| 2019-12-31 | ILA1.17 Million | ILA-1.15 Million | -0.978x | -88.16% |
| 2018-12-31 | ILA2.39 Million | ILA-1.24 Million | -0.520x | -14.45% |
| 2017-12-31 | ILA3.66 Million | ILA-1.66 Million | -0.454x | -54.05% |
| 2016-12-31 | ILA5.13 Million | ILA-1.51 Million | -0.295x | +87.25% |
| 2015-12-31 | ILA1.74 Million | ILA-4.01 Million | -2.312x | -162.46% |
| 2014-12-31 | ILA-884.00K | ILA-3.27 Million | 3.702x | +205.08% |
| 2013-12-31 | ILA342.00K | ILA-1.21 Million | -3.523x | -- |